The present invention relates to an antibody, which is capable of binding to theNeuromedin N long fragment, and Neurotensin long fragment with high […]
The present invention relates to modified T cells, and in particular to CD8 T cells, for use in therapy. The current inventors investigates the effect […]
The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza. In particular, […]
The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial infections. In particular, the present […]
The present invention relates to the treatment of infections due to antibiotic-resistant bacteria. Antimicrobial resistance (AMR) has been observed at […]
Antimicrobial resistance is a global problem, rendering conventional treatments less effective and requiring innovative strategies to combat this […]
The present invention relates to the treatment of infectious diseases. In this study, the inventors identified the potential protective mechanisms […]
The present invention relates to a hepcidin antagonist for use in the treatment of inflammatory diseases. TLR4-dependant intestinal hepcidin induces […]
There is an interest to develop anti-ROBO4 antibodies that can be suitable for the treatment of cancer. The inventors produced new human antibodies […]
In ovarian carcinoma, Müllerian Inhibiting Substance (MIS) type II receptor (MISRII) and the MIS/MISRII signaling pathway are potential therapeutic […]